Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 12, 2018
Company News

Shire to split neuro and rare disease businesses

BioCentury | Jan 9, 2018
Company News

Shire splits neuro and rare disease businesses

BioCentury | Aug 4, 2017
Company News

Shire evaluating neurology pipeline

BioCentury | Aug 3, 2017
Company News

Shire evaluating neurology pipeline

BioCentury | Apr 20, 2017
Clinical News

Vyvanse regulatory update

BioCentury | Aug 24, 2015
Clinical News

Vyvanse: Phase III data

BioCentury | Sep 29, 2014
Clinical News

Vyvanse regulatory update

BioCentury | Sep 15, 2014
Clinical News

Vyvanse: Phase IV data

BioCentury | Sep 15, 2014
Clinical News

Vyvanse: Phase IV data

Items per page:
1 - 10 of 22